Author:
Seley-Radtke Katherine L.,Kutz Christianna H. M.,Thames Joy E.
Publisher
Springer Nature Singapore
Reference65 articles.
1. Andersson J, Sköldenberg B, Ernberg I, Britton S, Henle W, Andersson U (1985) Acyclovir treatment in primary Epstein-Barr virus infection. A double-blind placebo-controlled study. Scand J Infect Dis Suppl 47:107–115
2. Barkholt L, Lewensohn-Fuchs I, Ericzon BG, Tydén G, Andersson J (1999) High-dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patients. Transpl Infect Dis 1(2):89–97
3. Chiang PK (1998) Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. Pharmacol Ther 77(2):115–134
4. Chudinov MV (2020) Nucleoside Analogs with Fleximer nucleobase. Chem Heterocycl Compd (NY, US) 56(6):636–643
5. Clercq ED, Holý A (2005) Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nat Rev Drug Discov 4(11):928–940